138 related articles for article (PubMed ID: 33174706)
1. [Not Available].
Meylan P
Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
[No Abstract] [Full Text] [Related]
2. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Nov; 16(714):2190. PubMed ID: 33174705
[No Abstract] [Full Text] [Related]
3. [COVID-19- what have we learned and where are we heading?].
Gudnason T
Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305
[No Abstract] [Full Text] [Related]
4. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
5. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
[No Abstract] [Full Text] [Related]
6. Influenza immunization and COVID-19.
Maltezou HC; Theodoridou K; Poland G
Vaccine; 2020 Sep; 38(39):6078-6079. PubMed ID: 32773245
[No Abstract] [Full Text] [Related]
7. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19.
Busch MH; Timmermans SAMEG; Nagy M; Visser M; Huckriede J; Aendekerk JP; de Vries F; Potjewijd J; Jallah B; Ysermans R; Oude Lashof AML; Breedveld PH; van de Poll MCG; van de Horst ICC; van Bussel BCT; Theunissen ROMFIH; Spronk HMH; Damoiseaux JGMC; Ten Cate H; Nicolaes GAF; Reutelingsperger CP; van Paassen P
Circulation; 2020 Nov; 142(18):1787-1790. PubMed ID: 32946302
[No Abstract] [Full Text] [Related]
8. [Not Available].
Meylan P
Rev Med Suisse; 2020 Jul; 16(700):1394. PubMed ID: 32672025
[No Abstract] [Full Text] [Related]
9. COVID-19 in Africa: Dampening the storm?
Mbow M; Lell B; Jochems SP; Cisse B; Mboup S; Dewals BG; Jaye A; Dieye A; Yazdanbakhsh M
Science; 2020 Aug; 369(6504):624-626. PubMed ID: 32764055
[No Abstract] [Full Text] [Related]
10. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
11. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
12. HIV and SARS-CoV-2: points to consider to face this new pandemic.
Prieto Pozo AA; Salvador Sagüez FLD
Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
14.
Olivares Gazca JC; Gómez Almaguer D; Gale RP; Ruiz Argüelles GJ
Hematology; 2020 Dec; 25(1):320. PubMed ID: 32783598
[No Abstract] [Full Text] [Related]
15. COVID-19 antibodies on trial.
DeFrancesco L
Nat Biotechnol; 2020 Nov; 38(11):1242-1252. PubMed ID: 33087898
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-related chilblains.
Ladha MA; Dupuis EC
CMAJ; 2020 Jul; 192(28):E804. PubMed ID: 32660940
[No Abstract] [Full Text] [Related]
17. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
18. Coronavirus vaccines get a biotech boost.
Dance A
Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
[No Abstract] [Full Text] [Related]
19. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.
Gruer L; Bhopal R
BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002
[No Abstract] [Full Text] [Related]
20. Cancer Patients and Risk of Mortality for COVID-19.
Curigliano G
Cancer Cell; 2020 Aug; 38(2):161-163. PubMed ID: 32710820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
